Astrazeneca (AZN) Net Cash Flow Growth (5y) (2014 - 2026)
Analysis
Astrazeneca (AZN) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.68% |
| Mar 31, 2026 | -8.84% |
| Dec 31, 2025 | -14.28% |
| Sep 30, 2025 | 20.33% |
| Jun 30, 2025 | 1.47% |
| Mar 31, 2025 | 75.44% |
| Dec 31, 2024 | 76.77% |
| Sep 30, 2024 | 27.37% |
| Jun 30, 2024 | -10.96% |
| Mar 31, 2024 | 26.48% |
| Dec 31, 2023 | 63.52% |
| Jun 30, 2023 | 109.80% |
| Mar 31, 2023 | 69.97% |
| Dec 31, 2022 | 37.07% |
| Jun 30, 2022 | 11.97% |
| Mar 31, 2022 | 114.49% |
| Dec 31, 2021 | -23.04% |
| Sep 30, 2021 | -117.58% |
| Jun 30, 2021 | 22.38% |
| Mar 31, 2021 | 28.25% |